INCREASED ACTIVITY OF HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE NEURONS IN MULTIPLE-SCLEROSIS

被引:66
作者
ERKUT, ZA
HOFMAN, MA
RAVID, R
SWAAB, DF
机构
[1] NETHERLANDS INST BRAIN RES,GRAD SCH NEUROSCI AMSTERDAM,1105 AZ AMSTERDAM ZO,NETHERLANDS
[2] NETHERLANDS BRAIN BANK,1105 AZ AMSTERDAM ZO,NETHERLANDS
关键词
MULTIPLE SCLEROSIS; HYPOTHALAMO-PITUITARY-ADRENAL AXIS; PARAVENTRICULAR NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; VASOPRESSIN; HUMAN HYPOTHALAMUS;
D O I
10.1016/0165-5728(95)00098-M
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical observations and animal studies suggest that the hypothalamo-pituitary-adrenal (HPA) axis plays a role in the susceptibility to and the recovery from multiple sclerosis (MS). Since the HPA-axis is under the control of corticotropin-releasing hormone (CRH) neurons of the hypothalamus, we determined 2 parameters for activation of the CRH neurons in the hypothalamic paraventricular nucleus (PVN) in MS patients. Since the HPA-axis is more activated in MS, we expected an increased activity of CRH neurons. We also expected to see an age-related increase in CRH activity, because of the possible role of the HPA-axis in the age-related decrease in susceptibility to MS. The number of CRH cell profiles and the proportion of CRH neurons co-expressing vasopressin were used as parameters for activity. CRH cell population became more activated both in control and MS patients, from 40 years of age onwards, when the prevalence of MS starts to decrease in the population The CRH neurons showed a significantly higher level of activation in MS patients than in controls, as appeared from the 3-fold increase in CRH cell number and the 4.5-fold increase in cells co-expressing CRH and vasopressin (AVP).
引用
收藏
页码:27 / 33
页数:7
相关论文
共 43 条
[31]   MULTIPLE-SCLEROSIS - IMMUNE-SYSTEM MOLECULE EXPRESSION IN THE CENTRAL-NERVOUS-SYSTEM [J].
RAINE, CS .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (04) :328-337
[32]   ADRENAL SIZE IS INCREASED IN MULTIPLE-SCLEROSIS [J].
REDER, AT ;
MAKOWIEC, RL ;
LOWY, MT .
ARCHIVES OF NEUROLOGY, 1994, 51 (02) :151-154
[33]   DEXAMETHASONE SUPPRESSION TEST ABNORMALITIES IN MULTIPLE-SCLEROSIS - RELATION TO ACTH THERAPY [J].
REDER, AT ;
LOWY, MT ;
MELTZER, HY ;
ANTEL, JP .
NEUROLOGY, 1987, 37 (05) :849-853
[34]   ULTRASTRUCTURE OF MULTIPLE-SCLEROSIS [J].
RODRIGUEZ, M ;
SCHEITHAUER, B .
ULTRASTRUCTURAL PATHOLOGY, 1994, 18 (1-2) :3-13
[35]  
SAWCHENKO PE, 1985, FED PROC, V44, P221
[37]  
SOBEL RA, 1988, AM J PATHOL, V131, P547
[38]   NO VASOPRESSIN CELL LOSS IN THE HUMAN HYPOTHALAMUS IN AGING AND ALZHEIMERS-DISEASE [J].
VANDERWOUDE, PF ;
GOUDSMIT, E ;
WIERDA, M ;
PURBA, JS ;
HOFMAN, MA ;
BOGTE, H ;
SWAAB, DF .
NEUROBIOLOGY OF AGING, 1995, 16 (01) :11-18
[39]   CHARACTERIZATION AND BIOLOGICAL-ACTIVITY OF A RAT MONOCLONAL-ANTIBODY TO RAT HUMAN CORTICOTROPIN-RELEASING FACTOR [J].
VANOERS, JWAM ;
TILDERS, FJH ;
BERKENBOSCH, F .
ENDOCRINOLOGY, 1989, 124 (03) :1239-1246
[40]   EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS AND CORTICOSTERONE STUDIES IN RESISTANT AND SUSCEPTIBLE RAT STRAINS [J].
VILLAS, PA ;
DRONSFIELD, MJ ;
BLANKENHORN, EP .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 61 (01) :29-40